Organization Overview
Alternative names
aflibercept (zaltrap) (1 trial)
allogeneic lymphocytes (1 trial)
anastrozole (arimidex) (1 trial)
bevacizumab (avastin) (1 trial)
bortezomib (velcade) (1 trial)
budesonide (rhinocort) (1 trial)
cabazitaxel (jevtana kit) (1 trial)
capecitabine (xeloda) (1 trial)
carboplatin (paraplatin) (2 trials)
copanlisib (aliqopa) (1 trial)
deferoxamine (desferal) (2 trials)
dehydroepiandrosterone (1 trial)
duloxetine (Cymbalta) (1 trial)
flecainide (tambocor) (1 trial)
fluorouracil (efudex) (4 trials)
gemcitabine (gemzar) (2 trials)
gemtuzumab ozogamicin (mylotarg) (1 trial)
imipramine (tofranil) (1 trial)
levobupivacaine (chirocaine) (1 trial)
mitomycin (mutamycin) (1 trial)
moricizine (ethmozine) (1 trial)
ofatumumab (arzerra) (1 trial)
Acute Pain (Phase 4)
Adenocarcinoma (Phase 2)
Adenocarcinoma, Clear Cell (Phase 2)
Adenomyoepithelioma (Phase 2)
Alcoholism (Phase 2)
Angina, Unstable (Phase 3)
Anus Neoplasms (Phase 2)
Anxiety Disorders (Phase 3)
Atherosclerosis (Phase 3)
Behavior, Addictive (Phase 3)
Body Dysmorphic Disorders (Phase 3)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Cardiovascular Diseases (Phase 3)
Cerebral Hemorrhage (Phase 2)
Chronic Pain (Phase 2)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Conversion Disorder (Phase 4)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 3)
Death, Sudden (Phase 3)
Death, Sudden, Cardiac (Phase 3)
Delayed Graft Function (Phase 2)
Delirium (Phase 4)
Depression (Phase 4)
Depressive Disorder (Phase 1)
Depressive Disorder, Major (Phase 3)
Disease (Phase 4)
Dissociative Disorders (Phase 4)
Dyssomnias (Phase 2)
Emergencies (Phase 1)
Eosinophilic Esophagitis (Phase 2)
Esophageal Neoplasms (Phase 1)
Esophagitis (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Familial Primary Pulmonary Hypertension (Phase 4)
Femoral Neck Fractures (Phase 2)
Fractures, Bone (Phase 4)
Gastrointestinal Neoplasms (Phase 1)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Gliosarcoma (Phase 2)
Head and Neck Neoplasms (Phase 1)
Heart Diseases (Phase 3)
Hematoma (Phase 4)
Hemorrhage (Phase 2)
Hip Fractures (Phase 2)
Hyperkinesis (Phase 4)
Hypertension (Phase 4)
Hypertension, Pulmonary (Phase 2)
Hypertension, Renovascular (Phase 3)
Hypertrophy (Phase 4)
Hysteria (Phase 4)
Infarction (Phase 3)
Infections (Phase 2)
Intestinal Neoplasms (Phase 1)
Ischemia (Phase 3)
Lacerations (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Liver Neoplasms (Phase 1)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Follicular (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Mantle-Cell (Phase 1)
Lymphoma, Non-Hodgkin (Phase 2)
Melanoma (Phase 2)
Mood Disorders (Phase 1)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 3)
Musculoskeletal Pain (Phase 2)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 3)
Neck Pain (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 1)
Neoplasms, Plasma Cell (Phase 2)
Nephrosis (Phase 4)
Nephrotic Syndrome (Phase 4)
Opioid-Related Disorders (Phase 3)
Pancreatic Diseases (Phase 3)
Pancreatic Neoplasms (Phase 3)
Parasomnias (Phase 2)
Peripheral Arterial Disease (Phase 3)
Peripheral Vascular Diseases (Phase 3)
Prostatic Neoplasms (Phase 2)
Rectal Neoplasms (Phase 2)
Renal Artery Obstruction (Phase 3)
Reperfusion Injury (Phase 2)
Schistosomiasis (Phase 2)
Schistosomiasis japonica (Phase 2)
Schistosomiasis mansoni (Phase 2)
Sclerosis (Phase 3)
Seizures (Phase 4)
Sleep Wake Disorders (Phase 2)
Somatoform Disorders (Phase 3)
Stomach Neoplasms (Phase 2)
Stress Disorders, Post-Traumatic (Phase 4)
Stress Disorders, Traumatic (Phase 4)
Substance-Related Disorders (Phase 4)
Suicidal Ideation (Phase 1)
Syndrome (Phase 4)
Uterine Cervical Neoplasms (Phase 2)
Vascular Diseases (Phase 3)
Ventricular Fibrillation (Phase 3)
Waldenstrom Macroglobulinemia (Phase 1)
Wounds and Injuries (Phase 2)